DK1087976T3 - Polymorf form af clopidogrel-hydrogensulfat - Google Patents

Polymorf form af clopidogrel-hydrogensulfat

Info

Publication number
DK1087976T3
DK1087976T3 DK99923711T DK99923711T DK1087976T3 DK 1087976 T3 DK1087976 T3 DK 1087976T3 DK 99923711 T DK99923711 T DK 99923711T DK 99923711 T DK99923711 T DK 99923711T DK 1087976 T3 DK1087976 T3 DK 1087976T3
Authority
DK
Denmark
Prior art keywords
hydrogen sulfate
polymorphic form
clopidogrel hydrogen
clopidogrel
polymorphic
Prior art date
Application number
DK99923711T
Other languages
Danish (da)
English (en)
Inventor
Andre Bousquet
Bertrand Castro
Jean Saint-Germain
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527349&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1087976(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1087976T3 publication Critical patent/DK1087976T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99923711T 1998-06-15 1999-06-10 Polymorf form af clopidogrel-hydrogensulfat DK1087976T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807464A FR2779726B1 (fr) 1998-06-15 1998-06-15 Forme polymorphe de l'hydrogenosulfate de clopidogrel
PCT/FR1999/001371 WO1999065915A1 (fr) 1998-06-15 1999-06-10 Forme polymorphe de l'hydrogenosulfate de clopidogrel

Publications (1)

Publication Number Publication Date
DK1087976T3 true DK1087976T3 (da) 2002-12-02

Family

ID=9527349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99923711T DK1087976T3 (da) 1998-06-15 1999-06-10 Polymorf form af clopidogrel-hydrogensulfat

Country Status (44)

Country Link
US (2) US6429210B1 (ko)
EP (1) EP1087976B1 (ko)
JP (1) JP3641584B2 (ko)
KR (1) KR100511238B1 (ko)
CN (1) CN1128805C (ko)
AP (1) AP1344A (ko)
AR (1) AR014854A1 (ko)
AT (1) ATE222256T1 (ko)
AU (1) AU752170B2 (ko)
BG (1) BG64508B1 (ko)
BR (1) BR9911219A (ko)
CA (1) CA2334870C (ko)
CO (1) CO5040084A1 (ko)
CZ (1) CZ299654B6 (ko)
DE (1) DE69902536T2 (ko)
DK (1) DK1087976T3 (ko)
DZ (1) DZ2817A1 (ko)
EA (1) EA002386B1 (ko)
EE (1) EE03972B1 (ko)
EG (1) EG24015A (ko)
ES (1) ES2181439T3 (ko)
FR (1) FR2779726B1 (ko)
HK (1) HK1033829A1 (ko)
HR (1) HRP20000863B1 (ko)
HU (1) HU225871B1 (ko)
ID (1) ID28264A (ko)
IL (2) IL139790A0 (ko)
IS (1) IS2469B (ko)
ME (1) ME00686B (ko)
MY (1) MY129439A (ko)
NO (1) NO327161B1 (ko)
NZ (1) NZ507914A (ko)
OA (1) OA11567A (ko)
PL (1) PL201894B1 (ko)
PT (1) PT1087976E (ko)
RS (1) RS49870B (ko)
SA (1) SA99200321B1 (ko)
SK (1) SK286340B6 (ko)
TR (1) TR200003417T2 (ko)
TW (1) TW562805B (ko)
UA (1) UA70323C2 (ko)
UY (1) UY25693A1 (ko)
WO (1) WO1999065915A1 (ko)
ZA (1) ZA200006386B (ko)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
DE60230327D1 (de) * 2001-12-18 2009-01-22 Teva Pharma Polymorphe von clopidogrel-hydrogensulfat
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
SG164279A1 (en) 2002-04-16 2010-09-29 Schering Corp Tricyclic thrombin receptor antagonists
AR040233A1 (es) * 2002-05-31 2005-03-23 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
WO2004048385A2 (en) * 2002-11-28 2004-06-10 Instytut Farmaceutyczny A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
DE10307343B4 (de) * 2003-02-21 2005-10-06 Volkswagen Ag On-Board-Diagnosevorrichtung und On-Board-Diagnoseverfahren für Kraftfahrzeuge
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
AU2003238664A1 (en) * 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
DK1618111T3 (en) 2003-04-25 2015-02-16 Cadila Healthcare Ltd Salts of clopidogrel and the process for preparing
JP2007516166A (ja) 2003-07-02 2007-06-21 エギシュ　ヂョヂセルヂャール　エルテー 血小板凝集阻害剤の無晶形の製法
ATE461201T1 (de) * 2003-07-02 2010-04-15 Egis Gyogyszergyar Nyilvanosan Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs
ES2387802T3 (es) * 2003-08-04 2012-10-02 Wockhardt Limited Procedimiento novedoso para la fabricación de bisulfato de (+)-(S)-clopidogrel forma I
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
CA2544443C (en) * 2003-11-03 2010-08-17 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
JP2007523203A (ja) * 2004-02-24 2007-08-16 ジークフリート・ジェネリクス・インターナショナル・アクチェンゲゼルシャフト クロピドグレルの薬理学的に許容できる塩
US7629465B2 (en) * 2004-03-05 2009-12-08 Ipca Laboratories Ltd. Industrial process for preparation of Clopidogrel hydrogen sulphate
JP4550884B2 (ja) * 2004-04-09 2010-09-22 ハンミ ファーム． シーオー．， エルティーディー． 結晶性クロピドグレルナフタレンスルホン酸塩又はその水和物、その製造方法及びそれを含む医薬組成物
PL1740593T3 (pl) * 2004-04-19 2016-09-30 Sposoby wytwarzania wodorosiarczanu klopidogrelu w formie polimorficznej I
EP1756116A1 (en) * 2004-04-20 2007-02-28 Sanofi-Aventis Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
EA010829B1 (ru) * 2004-04-20 2008-12-30 Санофи-Авентис Клопидогрель и его полиморфные формы
US7829720B2 (en) * 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
EP1704152A2 (en) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Crystalline clopidogrel hydrobromide and processes for preparation thereof
US7446200B2 (en) * 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
WO2006087729A1 (en) * 2005-02-15 2006-08-24 Usv Limited Rapid resolution process for clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph - form i
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
WO2006091847A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
WO2007086914A2 (en) * 2005-05-10 2007-08-02 Elan Pharma International, Limited Nanoparticulate clopidogrel formulations
US20070003615A1 (en) * 2005-06-13 2007-01-04 Elan Pharma International Limited Nanoparticulate clopidogrel and aspirin combination formulations
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
US7994322B2 (en) * 2005-09-05 2011-08-09 Cadila Healthcare Limited Processes for the preparation of different forms of (S)-(+)-clopidogrel besylate
JP2009507014A (ja) * 2005-09-21 2009-02-19 チョン クン ダン ファーマセウティカル コーポレイション Ｓ−クロピドグレルの新規レジネート複合体およびその生成法
WO2007091253A2 (en) * 2006-02-06 2007-08-16 C.T.S. Ltd. Pharmaceutical compositions comprising clopidogrel and vitamins which reduce homocysteine levels
US20070225320A1 (en) * 2006-03-27 2007-09-27 Eswaraiah Sajja Process for preparing clopidogrel
EP2001449A2 (en) * 2006-04-05 2008-12-17 Cadila Healthcare Ltd. Modified release clopidogrel formulation
CN102014899A (zh) * 2006-04-27 2011-04-13 因-斯韦特实验室有限公司 硫酸氢氯吡格雷多晶型物的制备方法
EP2044066A2 (en) * 2006-06-06 2009-04-08 Bristol-Myers Squibb Company Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide
TW200825093A (en) * 2006-08-03 2008-06-16 Teva Pharma Process for preparing clopidogrel bisulphate
EP2064217B1 (en) * 2006-09-04 2011-01-19 Ranbaxy Laboratories Limited An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
KR20080055356A (ko) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 보관안정성이 우수한 클로피도그렐 함유 포접 복합체
US20080194560A1 (en) * 2006-12-22 2008-08-14 Zhi Yun Wang Disintegration promoters in solid dose wet granulation formulations
WO2008093357A2 (en) * 2007-01-29 2008-08-07 Ipca Laboratories Limited Process for preparation of crystalline clopidogrel hydrogen sulphate form i
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
HUE053158T2 (hu) 2007-04-27 2021-06-28 Cydex Pharmaceuticals Inc Clopidogrelt és szulfoalkiléter ciklodextrint tartalmazó készítmények és alkalmazási eljárások
WO2009080469A1 (en) * 2007-12-24 2009-07-02 Sandoz Ag Process for the preparation of clopidogrel bisulphate form i
EP2095815B1 (en) * 2008-02-26 2011-10-26 Laboratorios Lesvi, S.L. Pharmaceutical formulations containing clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
EP3061460A1 (en) 2009-04-10 2016-08-31 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
PL3100728T3 (pl) 2009-05-13 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
KR101130445B1 (ko) * 2009-10-29 2012-03-27 동아제약주식회사 클로피도그랠 황산수소염 ⅰ형 제조방법
WO2011051976A2 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
WO2011125069A1 (en) 2010-03-22 2011-10-13 Rpg Life Sciences Limited A process for preparation of crystalline form i of clopidogrel bisulfate
ES2592280T3 (es) 2010-04-19 2016-11-29 Cadila Healthcare Limited Una composición farmacéutica que comprende agentes antiplaquetarios y un agente estimulante de eritropoyesis
AU2012277327B2 (en) 2011-06-27 2017-04-27 Ipca Laboratories Limited Anti-thrombotic compounds
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
CN102367257B (zh) * 2011-11-21 2014-05-07 天津红日药业股份有限公司 氯吡格雷盐酸盐的单晶晶型，它们的制备及应用
WO2014118802A1 (en) 2013-01-31 2014-08-07 Pharmazell Gmbh An improved process for the preparation of clopidogrel bisulfate form-i
WO2015015062A1 (fr) 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
CN103524528A (zh) * 2013-09-16 2014-01-22 吉林省博大伟业制药有限公司 一种改进的ⅱ型硫酸氢氯吡格雷结晶制备方法
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
CN110198705A (zh) 2017-01-23 2019-09-03 同和药品株式会社 包含hmg-coa还原酶抑制剂和氯吡格雷的复合制剂
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN109438467B (zh) * 2018-11-14 2021-03-26 四川青木制药有限公司 一种硫酸氢氯吡格雷ⅱ型球形结晶的制备方法
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.

Also Published As

Publication number Publication date
RS49870B (sr) 2008-08-07
HK1033829A1 (en) 2001-09-28
WO1999065915A1 (fr) 1999-12-23
US20020198229A1 (en) 2002-12-26
UA70323C2 (uk) 2004-10-15
SK19092000A3 (sk) 2001-05-10
NZ507914A (en) 2002-11-26
CZ299654B6 (cs) 2008-10-08
KR20010052835A (ko) 2001-06-25
HRP20000863B1 (en) 2003-04-30
HU225871B1 (en) 2007-11-28
ZA200006386B (en) 2001-05-07
ME00686B (me) 2008-08-07
IL139790A (en) 2006-10-05
HUP0104343A3 (en) 2003-03-28
NO327161B1 (no) 2009-05-04
EG24015A (en) 2008-03-24
FR2779726B1 (fr) 2001-05-18
JP3641584B2 (ja) 2005-04-20
DE69902536T2 (de) 2003-03-13
CN1305483A (zh) 2001-07-25
ATE222256T1 (de) 2002-08-15
IL139790A0 (en) 2002-02-10
PT1087976E (pt) 2002-11-29
ID28264A (id) 2001-05-10
PL201894B1 (pl) 2009-05-29
HRP20000863A2 (en) 2001-10-31
EE03972B1 (et) 2003-02-17
TW562805B (en) 2003-11-21
UY25693A1 (es) 2000-03-31
SK286340B6 (en) 2008-07-07
KR100511238B1 (ko) 2005-08-31
NO20006395L (no) 2001-02-15
CA2334870C (en) 2005-03-15
SA99200321B1 (ar) 2006-10-11
EA002386B1 (ru) 2002-04-25
OA11567A (en) 2004-05-24
ES2181439T3 (es) 2003-02-16
US6429210B1 (en) 2002-08-06
AR014854A1 (es) 2001-04-11
JP2002518399A (ja) 2002-06-25
BR9911219A (pt) 2001-03-06
CZ20004637A3 (cs) 2001-04-11
DE69902536D1 (en) 2002-09-19
EA200001187A1 (ru) 2001-08-27
CO5040084A1 (es) 2001-05-29
IS5716A (is) 2000-11-17
CA2334870A1 (en) 1999-12-23
AU752170B2 (en) 2002-09-05
AP1344A (en) 2004-12-15
AU4048399A (en) 2000-01-05
EE200000745A (et) 2002-04-15
TR200003417T2 (tr) 2001-03-21
NO20006395D0 (no) 2000-12-14
MY129439A (en) 2007-04-30
IS2469B (is) 2008-12-15
EP1087976B1 (fr) 2002-08-14
DZ2817A1 (fr) 2004-06-02
US6504030B1 (en) 2003-01-07
BG104987A (en) 2001-11-30
EP1087976A1 (fr) 2001-04-04
FR2779726A1 (fr) 1999-12-17
CN1128805C (zh) 2003-11-26
YU77700A (sh) 2003-04-30
AP2000001979A0 (en) 2000-12-31
HUP0104343A2 (hu) 2002-03-28
BG64508B1 (bg) 2005-05-31
PL344998A1 (en) 2001-11-19

Similar Documents

Publication Publication Date Title
DK1087976T3 (da) Polymorf form af clopidogrel-hydrogensulfat
ID27092A (id) Pembuatan ftalat anhidrida
DE60138197D1 (de) Überlaufbadewanne
DK1056722T3 (da) Hydrogensulfatsalt af HIV-protease-inhibitor
DK1016836T3 (da) Fremgangsmåde til tilvejebringelse af köling
DK0933414T3 (da) Reduktion af vandmængden produceret fra borehuller
DK1360287T4 (da) Fremgangsmåder til modifikation af eukaryotiske celler
PT945132E (pt) Composicao de ibuprofeno
DK1173760T3 (da) Indkodning af mikrobærere
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
ID26990A (id) Metode pembuatan dimetilnaftalena
ID28208A (id) Konstruksi penegang pengapung
DK1054985T3 (da) Produktion af hybridfrø
DK1090081T3 (da) Dispersion af pigmenter
DK1142990T3 (da) Fremgangsmåde til fremstilling af transglutaminase
DK1280803T3 (da) Krystallinsk form II af cabergolin
DK1155050T3 (da) Fremstilling af polyolefin
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
IS5821A (is) Kristalluð form af ósanetant
DK1246827T3 (da) Nye polymorfe former af olanzapin
DK0967202T3 (da) Fotolyse af 7-dehydrocholesterol
DK1088010T3 (da) Fremstilling af polyolefiner
PT1071397E (pt) Composicoes perorais de libertacao controlada de levosimendan
DE59800220D1 (de) Duschkabine
FR2808768B1 (fr) Installation d'imersion subaquatique